164 related articles for article (PubMed ID: 32277859)
1. The importance of uninterrupted albendazole treatment in patients with unresectable alveolar echinococcosis undergoing liver transplantation.
Zavoikin VD; Zelya OP; Tumolskaya NI
Transpl Infect Dis; 2020 Aug; 22(4):e13291. PubMed ID: 32277859
[TBL] [Abstract][Full Text] [Related]
2. Emerging human alveolar echinococcosis in Hungary (2003-2018): a retrospective case series analysis from a multi-centre study.
Dezsényi B; Dubóczki Z; Strausz T; Csulak E; Czoma V; Káposztás Z; Fehérvári M; Somorácz Á; Csilek A; Oláh A; Almási K; Patonai A; Görög D; Széll Z; Tolnai Z; Sréter T; Danka J; Auer H; Grüner B; Barth TFE; Casulli A
BMC Infect Dis; 2021 Feb; 21(1):168. PubMed ID: 33568075
[TBL] [Abstract][Full Text] [Related]
3. Impact of Albendazole on Cytokine and Chemokine Response Profiles in
Wu J; Ma HZ; Apaer S; Anweier N; Zeng Q; Fulati X; Li T; Zhao JM; Wen H; Tuxun T
Biomed Res Int; 2021; 2021():6628814. PubMed ID: 34041299
[TBL] [Abstract][Full Text] [Related]
4. Comparison of local ablation with Albendazole or laparoscopic hepatectomy combined with Albendazole in the treatment of early hepatic alveolar echinococcosis.
A J; Chai J; Shao Z; Zhao S; Wang H; A X; Yang J
Front Public Health; 2022; 10():960635. PubMed ID: 36276387
[TBL] [Abstract][Full Text] [Related]
5. In vivo efficacy of combination therapy with albendazole and atovaquone against primary hydatid cysts in mice.
Enkai S; Kouguchi H; Inaoka DK; Irie T; Yagi K; Kita K
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1815-1820. PubMed ID: 33770336
[TBL] [Abstract][Full Text] [Related]
6. In vivo activity of albendazole in combination with thymol against Echinococcus multilocularis.
Albani CM; Pensel PE; Elissondo N; Gambino G; Elissondo MC
Vet Parasitol; 2015 Sep; 212(3-4):193-9. PubMed ID: 26190130
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of albendazole in combination with thymol against Echinococcus multilocularis protoscoleces and metacestodes.
María AC; Celina EM
Acta Trop; 2014 Dec; 140():61-7. PubMed ID: 25149355
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of recombinant Em18-ELISA to evaluate efficacy of treatment in patients with alveolar echinococcosis.
Fujimoto Y; Ito A; Ishikawa Y; Inoue M; Suzuki Y; Ohhira M; Ohtake T; Kohgo Y
J Gastroenterol; 2005 Apr; 40(4):426-31. PubMed ID: 15870979
[TBL] [Abstract][Full Text] [Related]
9. ALVEOLAR ECHINOCOCCOSIS IN WESTERN LOWLAND GORILLAS (
Wenker C; Hoby S; Wyss F; Mengiardi B; Vögtli R; Posthaus H; Deplazes P; Gottstein B
J Zoo Wildl Med; 2019 Mar; 50(1):243-253. PubMed ID: 31120685
[No Abstract] [Full Text] [Related]
10. Efficacy of osthole for Echinococcus granulosus in vitro and Echinococcus multilocularis in vivo.
Yuan M; Luo Y; Xin Q; Gao H; Zhang G; Jing T
Vet Parasitol; 2016 Aug; 226():38-43. PubMed ID: 27514881
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of liver alveolar echinococcosis using echinococcosis multilocularis ultrasound classification.
Schuhbaur J; Schweizer M; Philipp J; Schmidberger J; Schlingeloff P; Kratzer W
World J Gastroenterol; 2021 Oct; 27(40):6939-6950. PubMed ID: 34790016
[TBL] [Abstract][Full Text] [Related]
12. Primary disease recurrence after liver transplantation for alveolar echinococcosis: long-term evaluation in 15 patients.
Bresson-Hadni S; Koch S; Beurton I; Vuitton DA; Bartholomot B; Hrusovsky S; Heyd B; Lenys D; Minello A; Becker MC; Vanlemmens C; Mantion GA; Miguet JP
Hepatology; 1999 Oct; 30(4):857-64. PubMed ID: 10498634
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of nanocompounds in the treatment of cystic and alveolar echinococcoses: challenges and future prospects.
Bakhtiar NM; Akbarzadeh A; Casulli A; Mahami-Oskouei M; Ahmadpour E; Nami S; Rostami A; Spotin A
Parasitol Res; 2019 Sep; 118(9):2455-2466. PubMed ID: 31402401
[TBL] [Abstract][Full Text] [Related]
14. Albendazole chemotherapy for human cystic and alveolar echinococcosis in north-western China.
Wen H; Zou PF; Yang WG; Lu J; Wang YH; Zhang JH; New RR; Craig PS
Trans R Soc Trop Med Hyg; 1994; 88(3):340-3. PubMed ID: 7974683
[TBL] [Abstract][Full Text] [Related]
15. Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study.
Bresson-Hadni S; Blagosklonov O; Knapp J; Grenouillet F; Sako Y; Delabrousse E; Brientini MP; Richou C; Minello A; Antonino AT; Gillet M; Ito A; Mantion GA; Vuitton DA
Liver Transpl; 2011 Jul; 17(7):855-65. PubMed ID: 21455928
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.
Abulaihaiti M; Wu XW; Qiao L; Lv HL; Zhang HW; Aduwayi N; Wang YJ; Wang XC; Peng XY
PLoS Negl Trop Dis; 2015; 9(9):e0003950. PubMed ID: 26352932
[TBL] [Abstract][Full Text] [Related]
17. Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity.
Stettler M; Rossignol JF; Fink R; Walker M; Gottstein B; Merli M; Theurillat R; Thormann W; Dricot E; Segers R; Hemphill A
Int J Parasitol; 2004 Apr; 34(5):615-24. PubMed ID: 15064126
[TBL] [Abstract][Full Text] [Related]
18. [An approach to the mechanism of matrine and albendazole against Echinococcus multilocularis infection in mice].
Zhang R; Jing T
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Oct; 24(5):366-9. PubMed ID: 17361819
[TBL] [Abstract][Full Text] [Related]
19. Albendazole nanocrystals in experimental alveolar echinococcosis: Enhanced chemoprophylactic and clinical efficacy in infected mice.
Pensel P; Paredes A; Albani CM; Allemandi D; Sanchez Bruni S; Palma SD; Elissondo MC
Vet Parasitol; 2018 Feb; 251():78-84. PubMed ID: 29426481
[TBL] [Abstract][Full Text] [Related]
20. Metformin improves the therapeutic efficacy of low-dose albendazole against experimental alveolar echinococcosis.
Loos JA; Coccimiglio M; Nicolao MC; Rodrigues CR; Cumino AC
Parasitology; 2022 Jan; 149(1):138-144. PubMed ID: 35184788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
